ENAP HL 20mg / 12.5mg tablets medication leaflet

C09BA02 enalapril + hydrochlorothiazide • Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics

The combination of Enalaprilum + Hydrochlorothiazidum is used for the treatment of essential hypertension in patients who do not respond adequately to monotherapy. It combines an angiotensin-converting enzyme (ACE) inhibitor (enalaprilum) with a thiazide diuretic (hydrochlorothiazidum) to lower blood pressure.

The medication is taken orally, usually once daily, and is effective in reducing the risk of cardiovascular complications such as stroke or heart failure.

Side effects may include dizziness, dry cough, nausea, hypokalemia, or increased uric acid levels. It is important to monitor blood pressure and kidney function during treatment.

Consult your doctor to discuss the benefits and risks of treatment with this combination. Follow the prescribed dosage and adhere to all medical recommendations.

General data about ENAP HL 20mg / 12.5mg

Substance: enalapril + hydrochlorothiazide

Date of last drug list: 01-07-2013

Commercial code: W42590004

Concentration: 20mg / 12.5mg

Pharmaceutical form: tablets

Quantity: 90

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: KRKA D.D. NOVO MESTO - ROMANIA

Holder: KRKA D.D. NOVO MESTO - SLOVENIA

Number: 7906/2015/04

Shelf life: 5 years

Concentrations available for enalapril + hydrochlorothiazide

10mg/12.5mg, 10mg/25mg, 20mg/12.5mg